Nektar Therapeutics announced that its lead candidate, rezpegaldesleukin, received Fast Track Designation from the FDA for eczema following encouraging performance in phase 2 studies. This regulatory ...
It is important to have a compressed air solution that achieves efficient and continuous operation, backed by local service.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback